Dermatological Drugs - Georgia

Georgia

The Dermatological Drugs market in Georgia is expected to witness a significant growth in revenue, reaching a projected value of US$2.69m by 2024.
This indicates a promising outlook for the market in the country.
Furthermore, it is anticipated that the revenue will continue to grow at an annual growth rate of 6.19%, leading to a market volume of US$3.42m by 2028.
In comparison to other countries, United States is expected to generate the highest revenue in the Dermatological Drugs market, with a staggering amount of US$13,260.00m in 2024.
This highlights the dominance of the United States in this market on a global scale.
The demand for dermatological drugs in Georgia has been steadily increasing due to the growing awareness and concern for skin health among the population.

Key regions: Brazil, Germany, Italy, Australia, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for dermatological drugs in Georgia has been steadily increasing in recent years.

Customer preferences: Georgian consumers have become more aware of the importance of skincare and are increasingly seeking out dermatological drugs to address their skin concerns. This trend is in line with the global rise in demand for skincare products and treatments.

Trends in the market: One of the key trends in the dermatological drugs market in Georgia is the growing popularity of natural and organic products. Consumers are becoming more conscious of the ingredients in their skincare products and are opting for products that are free from harsh chemicals. Another trend is the increasing availability of dermatological drugs online, with many consumers opting to purchase their skincare products through e-commerce platforms.

Local special circumstances: One of the unique factors influencing the dermatological drugs market in Georgia is the country's climate. The hot and humid summers can exacerbate skin issues such as acne and eczema, leading to a higher demand for dermatological drugs to address these concerns. Additionally, Georgia's traditional emphasis on natural remedies has led to a growing interest in traditional Georgian skincare ingredients such as honey and lavender.

Underlying macroeconomic factors: Georgia's growing economy and rising middle class have contributed to the increasing demand for skincare products, including dermatological drugs. Additionally, the country's tourism industry has played a role in driving demand, with tourists often seeking out skincare products to take home as souvenirs. Finally, the COVID-19 pandemic has led to a shift in consumer behavior, with many consumers prioritizing their health and wellness, including their skincare routines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.